From 28–30 April 2026, healthcare professionals from across Central Asia will gather in Tashkent for the 30th anniversary of TIHE (Tashkent International Healthcare Exhibition), one of the leading medical exhibitions in Uzbekistan. At TIHE, Ozelle will showcase its new generation of AI-powered brand CBC machines at stand D14, offering visitors a hands-on look at how Complete Blood Count (CBC) testing is being transformed by imaging, artificial intelligence, and all‑in‑one design.

If you are searching for a reliable CBC machine that combines accurate hematology, smart automation, and compact design, TIHE 2026 will be the ideal place to compare systems side by side, talk directly with product specialists, and explore partnership models tailored to local markets.

Why TIHE 2026 Is the Right Place to Choose a Reliable CBC Machine

TIHE has become a key healthcare and medical technology exhibition in Uzbekistan, bringing together manufacturers, laboratory solution providers, and healthcare decision-makers.

For buyers, this concentration of suppliers makes it one of the most efficient venues in the region to evaluate CBC and hematology solutions in a single visit.

For buyers evaluating a new brand CBC machine, an in‑person visit to TIHE offers several advantages:

• Compare multiple CBC and hematology systems through live demonstrations and sample testing.
• Discuss technical specifications, pricing, and service models directly with product specialists.
• Evaluate not only analyzer performance, but also consumables, connectivity, and long-term operating costs.

At stand D14 at TIHE, Ozelle will present its EHBT‑25, EHBT‑50, and EHBT‑75 analyzers as a coherent brand CBC machine family, covering the needs of primary care clinics, multi‑specialty centers, and hospital laboratories across Central Asia.

Meet Ozelle: From Silicon Valley Lab to Global CBC Machine Brand

Ozelle is a diagnostic technology company advancing the fourth generation of hematology analysis through AI × Complete Blood Morphology (AI × CBM). Founded in Silicon Valley in 2014, Ozelle develops intelligent diagnostic systems that combine high-resolution cellular imaging with AI-powered analysis to enable scalable blood cell morphology assessment.

Traditional hematology analyzers provide reliable numerical parameters, yet morphology interpretation has long depended on expert microscopic review. Ozelle addresses this challenge through AI × CBM, enabling standardized and consistent morphology assessment across instruments, operators, and clinical environments.

Ozelle systems integrate analyzers, AI-powered morphology analysis, and an AI Workbench that organizes diagnostic data and highlights abnormal cellular findings within clinical workflows.

Within this system, different product lines play specific roles: the EHBT‑25 cell morphology hematology analyzer brings AI‑enhanced 3‑diff CBC into primary care and POCT sites, the EHBT‑50 Mini Lab multi‑functional analyzer combines 7‑diff CBC, immunoassay, and biochemistry on a single console, and the EHBT‑75 auto hematology analyzer delivers advanced morphology and automation for larger laboratories.

At TIHE 2026, visitors will be able to see how these analyzers, the AI Workbench, and Ozelle’s AI × CBM engine work together as one ecosystem rather than isolated machines, setting the stage for the product‑focused sections that follow.

To learn more about Ozelle’s hematology portfolio and AI‑driven diagnostics, you can also explore the official website at Ozelle – AI‑Powered Hematology & CBC Solutions.

EHBT‑25: Compact Brand CBC Machine for Primary Care

As an entry point into Ozelle’s brand CBC machine family, the EHBT‑25 is a compact cell morphology hematology analyzer designed for primary care clinics, community health centers, pharmacies, and mobile or occupational health services. It delivers 3‑diff CBC with AI‑enhanced morphology, using only a small fingertip or capillary blood sample.

Key Features of EHBT‑25

AI-supported morphology analysis based on image detection

Approximately 21 CBC parameters with 3-part WBC differential

Dry cartridge design that simplifies operation and reduces maintenance

Small sample volume (40–45 µL), suitable for near-patient testing

For clinics whose primary need is routine CBC for infection screening and anemia checks, the EHBT‑25 offers a cost‑effective brand CBC machine option that can later be complemented by the EHBT‑50 as test menus expand.

EHBT‑50 Mini Lab: All‑in‑One Brand CBC Machine for Clinics

O EHBT‑50 Mini Lab is Ozelle’s flagship multi‑functional brand CBC machine, designed as a compact “mini lab” for outpatient clinics, primary care centers, and decentralized diagnostic units that need more than classical CBC counts.

Key Technical Highlights

• 7‑diff CBC with CBM: Hematology analysis covers red blood cells, white blood cells, and platelets, with 41 CBC parameters including NST, NSG, NSH, RET, PAg, ALY, NLR, and PLR.
• All-in-One
  • Hematology (CBC and morphology)
  • Imunoensaio (via Fluorescence Immunoassay) for inflammation (CRP, SAA), cardiac markers (cTnI, NT‑proBNP, etc.), thyroid function, anemia, and more.
  • Dry‑Chemistry Biochemistry for glucose, lipid, liver, and kidney function panels
• Single‑use cartridges: An all‑in‑one hematology cartridge stores reagents and waste liquid, offering a shelf life of up to 2 years at room temperature; immunoassay and biochemistry consumables are also designed for convenient storage and logistics.
• Fast workflow: EHBT‑50 typically delivers combined CBC and morphology results in about 6 minutes using 30–100 µL of capillary or venous blood, with no manual sample pre‑treatment required.

Designed for Real‑World Clinics

The EHBT-50 is designed for real-world clinical settings where ease of use and workflow efficiency are critical. Features that matter at this level include:

• A 10.1‑inch touch screen with guided interface and visual placement prompts for cartridges and counting chambers.
• Smart built‑in cameras to check correct consumable placement before each run, reducing handling errors.
• Maintenance‑free design with dry‑type architecture and sealed cartridges, reducing breakdown risk and service complexity.
• Integrated smart diagnosis modules that interpret combinations of CBC, immunoassay, and biochemistry results to suggest possible infection or inflammation patterns, while still leaving final judgment to clinicians.

For clinics in Uzbekistan and Central Asia that want to introduce or upgrade in‑house CBC testing, the EHBT‑50 offers the combination of brand‑level accuracy, multi‑parameter coverage, and compact footprint—qualities that you will be able to see directly at stand D14 during TIHE 2026.

EHBT‑75: Professional Brand CBC Machine for Labs

Ozelle's EHBT‑75 auto hematology analyzer serves as a professional 7‑diff solution for core and reference labs. It shares the same AI and optical foundations as the mini‑lab, but is configured specifically for dedicated hematology workflows in hospital laboratories.

Key attributes of the EHBT‑75 as a brand CBC machine include:

• 41 hematology parameters with extensive white blood cell sub‑classification, reticulocyte analysis, and platelet morphology insights.
• Advanced CBM imaging pipeline, using Z‑stack scanning and high‑definition optics to generate slide‑like images without manual smear preparation.
• Validation studies show strong correlation with established hematology analyzers from leading manufacturers, supporting its use in routine laboratory workflows.
• Integrated smart diagnostic support that can highlight likely bacterial vs viral infection patterns or bone marrow response based on combined CBC data, presenting this analysis in clear language on the report.

Visitors to TIHE 2026 will be able to compare how the EHBT‑25, EHBT‑50, and EHBT‑75 differ in depth of hematology, workflow design, and target scenarios, ensuring they can choose the right brand CBC machine for their specific level of care.

CBM, AI, and IoT: Beyond a Single CBC Reading

At the system level, Ozelle separates on-device intelligence from network-level connectivity. The AI Workbench operates within each analyzer as the user-facing layer, organizing test results, visualizing cell morphology, and highlighting abnormal patterns to support consistent interpretation at the point of care.

Complementing this, Ozelle’s IoT and cloud services connect multiple sites and devices into a unified data network. This enables distributors and group operators to monitor instrument status, reagent usage, and quality performance across locations, while laboratory teams can access structured data for quality control, audit tracking, and workflow standardization.

Through this architecture, Ozelle’s AI × CBM solution presented at TIHE 2026 is positioned not simply as a standalone CBC analyzer, but as a scalable diagnostic system—where analyzers generate reliable data, AI Workbench standardizes interpretation at the user level, and connected infrastructure supports system-wide visibility and consistency.

How Ozelle Fits Into the Global Brand CBC Machine Landscape

The global hematology analyzer market is shifting toward compact, multi-functional systems with integrated AI capabilities. At the same time, cost efficiency and operational simplicity are becoming key decision factors, especially in emerging markets. Analysts note that demand for CBC testing is growing in primary care, chronic disease management, oncology, while budgets remain constrained—especially in emerging markets.

In this context, Ozelle positions itself as a brand CBC machine provider focused on:

• Consolidation: Combining CBC, immunoassay, and biochemistry into a single EHBT‑50 analyzer to reduce equipment footprint and simplify training, with EHBT‑25 and EHBT‑75 providing complementary options at entry‑level and advanced tiers.
• Accessibility: Using room‑temperature cartridges, maintenance‑free designs, and small sample volumes to make advanced diagnostics viable in clinics beyond tertiary hospitals.
• Intelligence: Embedding AI‑based morphology recognition and clinical interpretation into all EHBT series analyzers, upgrading routine CBC into deeper diagnostic insight.

TIHE 2026 offers healthcare decision‑makers in Uzbekistan the chance to see how this approach compares to more traditional CBC brand offerings and to evaluate which strategy best matches their patient volumes, staffing, and budget.

Plan Your Visit: Find Ozelle’s Brand CBC Machines at TIHE 2026

TIHE 2026 will take place from 28–30 April 2026 in Tashkent, with a focus on medical equipment, laboratory technologies, and healthcare innovations. Ozelle will exhibit its AI‑powered brand CBC machines—including the EHBT‑25, EHBT‑50 Mini Lab, and the EHBT‑75 professional analyzer—at:

• Company: Ozelle, GmbH
• Stand: D14
• Location: TIHE, Tashkent, Uzbekistan

At the stand, visitors can:

• Experience live demonstrations of CBC, immunoassay, and biochemistry workflows
• Review detailed reports, including numerical parameters and cell images
• Explore distribution opportunities and localized service support

To prepare for your visit to TIHE, you can explore Ozelle’s product pages and hematology solutions on the official website: https://ozellemed.com/en/.